Should I stay (Private) or should I go (Public)?

Is this the yearIs this the year that biotech IPO's recover? How do you know when to make the leap? Join this panel to discuss how to truly thrive in the challenging and rapidly evolving biotech environment and debate when is the right time to make the leap. Hear from influential investors, public CEOs, and leaders of private companies (for now) to learn key real-world implications. At the end of the day, what will best enable biotech innovation to continue to thrive?